Cambridge Cognition Share Discussion Threads

[jasperlachat] 12/9/2024 15:04

Beat me to it earwacks! Cog is in commercial mode now, thanks Storky but a replacement driver required.

[nchanning] 12/9/2024 15:00

I guess we'll see if his LinkedIn profile changes next week then he probably walked . If he does nothing for a few months perhaps the pursuing other opportunities was just a polite way of pushing him off the plank

[earwacks] 12/9/2024 14:55

Did he jump or was he pushed? Must at least be a mutual arrangement. A ceo doesn’t usually just walk because he fancies a better job. I would think there will be plenty of good candidates, not least Dr Jenny Bartlet. As have said before I am more confident in her leadership and communicative skills. Good riddance frankly

[nchanning] 12/9/2024 14:44

I'd put in the potentially bad but possibly irrelevant category . If he got an offer from a bigger company with a bigger salary it may not mean much that he decided to take it . It probably means he didn't think his unvested stock options were about to rocket though ....

[cerrito] 12/9/2024 14:33

Been a bit tied up today so just catching up with this.
Yes we are that much more vulnerable to a takeover but I have no idea what the reaction of Nigel Wray,L Odier ,Canaccord and the rest will be.
Not an ideal situation that no CFO or CEO. Depending on how good the Financial Controller is the lack of a CFO could be handled but I assume there will be no replacement until they have found a CEO.
Take comfort from the fact that the Chairman has on paper the required experience and when he was CEO of an AIM company I had shares in 15 odd years ago-cannot remember the name-he gave a good impression.
Well done to those on the ball who bought after the news broke and bought in in the last hour.
Good point about the salary saving.

[bedford1976] 12/9/2024 14:25

The positive is we are saving 430k + on his salary. I guess he also forfeits share options once you have resigned.
Considering Stork had a large amount of options this could be a big win for the shareholder.

[bedford1976] 12/9/2024 14:04

Well Stork has gone with 'immediate affect'.This really leaves us vulnerable to a takeover.
I have some shares in STV and when Simon Pitts resigned we had a year to find a replacement.
Such a sudden departure could mean a number of things. The best scenario being he's just got a better job elsewhere.

[bmcollins] 12/9/2024 11:43

RNS has just announced that the "CEO is stepping down with immediate effect", this does not sound like good news, does anyone have a view ?

[cerrito] 10/9/2024 12:05

Thanks for ferreting that out,40 Fathoms

[40 fathoms] 05/9/2024 12:33

This was posted today, no RNS but interesting nonetheless.

Don't seem able to post the link, so here is a copy of the text

"US patient recruitment firm Splash Clinical has teamed up with UK-based digital brain health services provider Cambridge Cognition (COG) to help sponsors find people to participate in central nervous system (CNS)-focused drug trials.

The new partnership – financial terms of which were not disclosed – will see Splash utilize COG’s pre-screening technology to assess potential participants for studies focusing on CNS indications.
In a press statement, Splash CEO Matt Teuteberg, said, “By integrating their assessment tools into our platform, we will increase our efficiency in finding the right patients for clinical trials. This partnership will save time and resources for our clients and ultimately make treatments available for patients faster.”
CNS recruitment

Finding the right patients to take part in drug research is always difficult, nonetheless of the disease involved. Recruiting for trials focusing on neurological disorders is a particular challenge.
For example, a 2023 study in the journal Innovations in Clinical Neuroscience suggested the lack of information about CNS patients combined with the nature of the diseases themselves are the issue.
“In contrast to other therapeutic areas, such as oncology or cardiovascular diseases, there are no large clinical research networks for CNS, making it more difficult to efficiently reach patients in their care setting. There are also challenges associated with CNS disorders themselves that are not relevant to other therapeutic areas … Thus, the timely recruitment and retention of the right and representative patients is a challenge for CNS clinical trials.”

COG’s technology is designed to address such difficulties. The system consists of an online cognitive assessment portal that gathers and processes data from potential study participants. According to the firm, the assessment, which takes around ten minutes, reduces screening failures and increases the quality of patients entering the trial.

Splash said that, in combination with its own suite or recruitment tools, the new tech will help it reach a broader population while maintaining high-quality standards.

Liam Kaufman, Cambridge Cognition’s vice president of clinical sciences, emphasized the potential benefits of the collaboration, explaining “They’ve got a great recruitment platform and a solid track record in recruitment. Our tools complement their process perfectly. Our goal is to make it easier for researchers to find the right participants for their CNS trials. It’s a win-win for everyone involved.”

She added that during a pilot collaboration completed last year, COG’s software helped filter in hard-to-find patients with early Alzheimer’s symptoms.

News of the collaboration comes a few months after the Michael J. Fox Foundation began using COG’s technology to identify the cognitive profile of Parkinson’s Disease patients as part of an effort to identify biomarkers – and potential druggable targets – for the condition.

[bmcollins] 31/8/2024 10:30

@earwacks
You will find some on youtube, there are 2 interviews with management by proactive investors, most recent one 8 months ago & the latest posting is a piece by share price Angel's head of health care giving his thoughts which is only 3 months old.

[earwacks] 31/8/2024 09:25

I remember a few years back a director of an aim company telling me his solicitor advised reporting as a little to the market as possible and preferably nothing at all. Some seem to have turned this in to an absolute art form, others seem to court the market too much. You only have to look at the top holders list in COG to see they are not too bothered with investor relations with PIs. I seem to remember Vox markets or Paul Scot saying they hoped to do an interview with Cog. Presumably too busy or not keen. It does seem that private investor’s frequent trades can mess with the share price on very low volumes. I guess this can become an issue with small companies when trying to raise finance

[40 fathoms] 31/8/2024 08:03

For reasons known only to them, they never publish a copy of the investor meeting or the investor deck. This is very frustrating and unnecessarily complicates the process of monitoring or researching the company.

[cerrito] 30/8/2024 14:43

As a matter of interest did any of you make the presentation ?and any reaction?
I could not find it on the website.

[bmcollins] 28/8/2024 15:49

But efficient if the company wishes to filter out difficult questions though ?

[cerrito] 28/8/2024 15:22

Hope some of you made the webinar.
Yesterday I received the dial in instructions and in my naivety assumed that was all that was required.
Tried to log in just after 4 told I had to submit my questions and then told they were vetting me.
Promised email did not come.
Not very efficient

[greyingsurfer] 25/8/2024 08:12

Most public sector workers have seen real terms pay cuts over the past 14 years, while private sector workers have generally kept up with inflation overall. It was inevitable that some catching up had to happen. The costs of strikes, inability to keep essential skilled people like nurses, considerably out weigh the costs of failing to act. (Not sure what this, or the post I'm responding to has to do with COG though?)

[horseyphil] 24/8/2024 17:57

'Brighter Tomorrow' if you are in the public sector...until other people's money runs out! We're on a downward trajectory as Labour pays back the unions. But it's the total incompetence of the Tory governments from 2010-24 that's brought all this on.

Ironic that GBP is showing such strength, belies the economic realities and, at some point, will be a great short. The UK economic future is dire, imho. Fortunately, most of our better companies earn the majority of their revenues abroad, COG included I imagine.

[40 fathoms] 24/8/2024 16:24

All pretty depressing if you think too much about it. We are going to have to “eat bitter” for that brighter tomorrow that we are assured is on the horizon.

[greyingsurfer] 24/8/2024 14:36

That's fine, if the savings are intended for the kids. If they are part of your retirement/old age planning it's not a great idea.

[earwacks] 24/8/2024 11:39

@bmcollins. It looks on the cards doubt we will even get the extra 5k for Isa for British stock. Guess the best idea regarding IHT is to put the stocks in the kids names now. Can you still manage it though without setting up a trust?

[bmcollins] 24/8/2024 11:27

@earwacks
Re IHT I think nothing can be taken for granted with the budget due in October, given that the govt have already hinted IHT could be affected (certainly not down, upwards only!) they may well decide the IHT concession could be removed.
I think it is best to assume the worst and hope for something less bad, taxwise.

[earwacks] 24/8/2024 11:03

@40Fathoms. End of September when the loan note news was made public the share price was @92p. By the time they issued the warrants on October 5th the share price had dropped to low 70s. I think the key is what date the execution of the loan took place. Unless it was written in stone about the 91p looks like the 5 day average weighting was around 74 p. The only thing definite in the September RNS is that the warrants will equate to £540000. About £125000 difference, unfortunate but in the grand scheme maybe not too bad. Probably took them by surprise, as they thought the loan was the better fund raise option. Then all the delays kicked in and we are where we are. I wouldn’t have bought anymore if not for the drop, so in the long run if it works out will be in a better position. Looking back on the mysterious ‘ existing investor’ they took 955000 shares which is about £325,000. So maybe not Claret as I don’t recall them having any shares. Hoping this is one of those IHT free stock. Trouble is good aim companies keep getting taken over, so not a very reliable plan long term!

[40 fathoms] 24/8/2024 10:13

earwacks - Thank you for this. In order to highlight the discrepancy on warrant pricing between the RNS and the Annual Report, please see the copied section below (Page 75).

"On 26 September 2023, the Group entered into a £3.0 million term loan. The term loan is repayable over three years, with an initial six-month interest only period. Interest is incurred at a fixed rate of 11.5% of the outstanding principal. The debt is secured via a floating charge over the assets of the Company and Cambridge Cognition Limited.
Alongside this term loan, the Group issued 722,565 warrants with an exercise price of 91p."

My money is on the AR being the correct figure as it will have been checked by the Auditor.

[earwacks] 24/8/2024 07:38

@40 Fathoms. Indeed. October 5th 2023. Claret were given the right to subscribe to any future funding up to £500,000. I guess it is possible that they did participate in the placing. Seem to remember a separate note about an investor taking somewhere around 900,000 shares in addition to the offer which fits the £500,000 deal I mentioned but not notifiable. Curiously 74p is about where it needs to be for me to break even, having added a few more yesterday. The warrants issued for subscription are 722,565 @.74.734 being the lower average weighted price 5 days preceding execution of the £3 million loan note. So potentially Claret could inject another £540,000. Might be a while before they decided to do that funded by the interest they receive on the loan note!